Email this article Prognostic factors in incidental prostate carcinoma patients
- Authors: Glubochco P.V.1, Ponucalin A.N.1, Popova T.N.1, Orlova Y.I.1, Korolev A.Y.1, Bigbaev R.R.1
-
Affiliations:
- Saratov state medical university. Department of urology
- Issue: Vol 4, No 1 (2008)
- Pages: 41-44
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER
- Published: 30.03.2008
- URL: https://oncourology.abvpress.ru/oncur/article/view/1040
- DOI: https://doi.org/10.17650/1726-9776-2008-4-1-41-44
- ID: 1040
Cite item
Full Text
Abstract
The long-term outcomes of treatment of 117 patients with prostate cancer revealed during adenomectomy were studied. Histological analysis of the adenomatous tissue showed that patients had stage T1a-bNoM0 in 62(52,9%), T2N0M0 in 33(28,2%), T3N0-1M0 in 22(18,8%) cases. G1 adenocarcinoma was identified in 85(72,6%) patients, G2 and G3 adenocarcinoma - in 32(27,4%) patients. Three methods of treatment were used: hormonal therapy, active surveillance and hormonal therapy with radiotherapy. Our results indicate that significant prognostic factors in incidental prostate carcinoma are: age, pT stage , histological grade as well as adjuvant xR- therapy.
About the authors
P. V. Glubochco
Saratov state medical university. Department of urology
Author for correspondence.
Russian Federation
A. N. Ponucalin
Saratov state medical university. Department of urologyRussian Federation
T. N. Popova
Saratov state medical university. Department of urologyRussian Federation
Y. I. Orlova
Saratov state medical university. Department of urologyRussian Federation
A. Y. Korolev
Saratov state medical university. Department of urologyRussian Federation
R. R. Bigbaev
Saratov state medical university. Department of urologyRussian Federation
References
Supplementary files
